Today

Agents

Chat

Arena

Discover

More

App

Nektar Therapeutics Q2 EPS USD -1.23 - NKTR News | Rallies

Nektar Therapeutics Q2 EPS USD -1.23

NKTR•2026-08-13

Nektar Therapeutics reports second-quarter results

Aug. 13 (Reuters) - Nektar Therapeutics Q2 net income was USD -40.622 million.

Q2 product sales: USD 10.131 million

Related News

Exxon oil output in Guyana down in May and June, government data shows

XOM•2026-08-13

Waystar CEO Matthew J. Hawkins disposes of 82,500 common shares for $2.06 million

WAY•2026-08-13

Pershing Square swings to Q2 net loss of USD 42.7 million; revenue rises 2% to USD 54.18 million

PS

•

2026-08-13

Caribou Biosciences Q2 net loss narrows

CRBU•2026-08-13

Nubank quarterly net profit beats estimates, topping $1 billion for first time

NU•2026-08-13